BD Selects Alverix to Develop Instrumentation to Be Part of New System to Improve Infectious Disease Diagnoses at Point-of-Care When combined with existing diagnostic tests, or with assays currently ...
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, today introduced two new erythrocyte sedimentation rate (ESR) instruments in Europe that ...
FRANKLIN LAKES, N.J., Sept. 30, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2 ...
Becton, Dickinson and Co. (BD) said today that it acquired its partner and key supplier in developing the BD Veritor™ System, privately held Alverix, in a $40 million deal designed to grow BD’s ...
After years of collaboration, Becton Dickinson ($BDX) is buying out San Jose, CA's Alverix, deepening its holdings in point-of-care testing and expanding its palette ...
- Simple new assay leverages more than 25,000 BD Veritor™ instruments already used across the U.S. to immediately increase access to COVID-19 testing in frontline health care settings - BD will begin ...
DUBLIN--(BUSINESS WIRE)--The "Point of Care Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. Globally, the diagnostic testing business is a ...
SAN JOSE, Calif.--(BUSINESS WIRE)--As consumers begin to take greater ownership of their own healthcare, there is a growing demand for accessibility to diagnostic testing. Alverix, Inc. and BD (Becton ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results